PCI術(shù)對超高齡（≥80歲）心肌梗死患者心臟功能的遠期療效探討

　　[摘要] 目的 探討PCI術(shù)對年齡不低于80歲的超高齡心肌梗死患者進行治療后患者心臟功能的遠期療效。 方法 選擇2014年6月～2017年5月期間于我院接受治療的200例超高齡心肌梗死患者，將其按隨機的方式進行分組，對照組與試驗組各100例。對照組的治療方法為藥物治療，試驗組的治療方法為PCI治療，治療結(jié)束后對患者予以5～40個月的隨訪，將患者最后一次檢查的LVEF指標、左心室質(zhì)量指數(shù)等指標以及患者的死亡率進行比較。 結(jié)果 試驗組患者的LVEDV、LVESV水平均顯著低于對照組，而LVEF水平顯著高于對照組，差異有統(tǒng)計學(xué)意義（P<0.05）。試驗組的LVMI、LVD指標的水平均顯著低于對照組，差異有統(tǒng)計學(xué)意義（P<0.05）；而IVST、LVPWT水平與對照組相比無明顯差異（P>0.05）。隨訪結(jié)果顯示，試驗組的死亡率為3.00%（3/100），對照組的死亡率為16.00%（16/100），差異有統(tǒng)計學(xué)意義（χ2=9.83，P=0.00<0.05）。 結(jié)論 從遠期來看，用PCI術(shù)對年齡不低于80歲的超高齡心肌梗死患者進行治療后，患者的心臟功能得到較為明顯的改善，且患者的死亡率較低，因而PCI術(shù)具有一定的推廣意義。
　　[關(guān)鍵詞] 超高齡心肌梗死；PCI術(shù)；心臟功能；遠期療效
　　[中圖分類號] R542.22 [文獻標識碼] A [文章編號] 1673-9701（2018）08-0004-03
　　Long-term effectiveness of PCI on cardiac function in very elderly （≥80 years） patients with myocardial infarction
　　ZHAO Zhongliang
　　Department of Cardiology， Wafangdian Central Hospital in Liaoning Province， Wafangdian 116300， China
　　[Abstract] Objective To investigate the changes of cardiac function after the treatment of PCI in very elderly patients who were aged no less than 80 years with myocardial infarction from the aspect of long-term effectiveness. Methods 200 very elderly patients with myocardial infarction in our hospital from June 2014 to May 2017 were selected and divided into control group and study group randomly with 100 patients in each group. Patients in control group were treated with medication and patients in study group were treated with PCI. Patients were followed up for 5 to 40 months after treatment. The levels of LVEF and left ventricular mass index and the mortality of patients were compared. Results The levels of LVEDV and LVESV in study group were significantly lower than those in control group while the level of LVEF in study group were significantly higher than that in control group（P<0.05）. The levels of LVMI and LVD were significantly lower than those in control group（P<0.05）. There were no statistical differences of the levels of IVST and LVPWT between study group and control group（P>0.05）. Results of follow-up showed the mortality in study group was 3.00%（3/100） while that in control group was 16.00%（16/100）（χ2=9.83， P<0.05）. Conclusion From long-term point of view， cardiac function is improved significantly and the mortality is low after the treatment of PCI in very elderly patients who are aged no less than 80 years with myocardial infarction. Thus， PCI is worth promotion.
　　[Key words] Very elderly with myocardial infarction； PCI； Cardiac function； Long-term effectiveness

相關(guān)熱詞搜索：心肌梗死 遠期 高齡 療效 患者